News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
102last 24h
3125last 7d
511● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.79d agoneutral
Is Biogen (BIIB) Undervalued On Raised EPS Guidance And Key Phase 3 Readouts?Simply Wall St.79d agoneutral
What Biogen (BIIB)'s Higher Earnings Guidance and Late-Stage Pipeline Progress Means For ShareholdersInvestor's Business Daily95d agoneutral
Biogen Stock: How To Find & Own America's Greatest OpportunitiesSimply Wall St.101d agoneutral
Biogen (BIIB) Is Up 5.8% After Earnings Compression Amid Revenue Growth - Is Profitability Peaking?GuruFocus.com102d agoneutral
Biogen Inc (BIIB) Q2 2026 Earnings Call Highlights: Strong Growth in Core Pharmaceuticals and ...BioPharma Dive102d agoneutral
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology pushBarrons.com102d agoneutral
Biogen Raises Revenue Guidance as Growth Portfolio Outpaces Legacy Blockbuster DrugsStockStory103d agoneutral
Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings